Overview

The enactment of the Gene Technology Act 2000 by the Australian Parliament addresses the need to regulate the use, handling, and release of genetically modified organisms (GMOs) in Australia. This legislation was introduced to fill the gap left by the absence of a comprehensive regulatory framework governing GMOs, ensuring their safe and responsible use while considering human health and environmental protection. The Act established the Office of the Gene Technology Regulator, which assesses applications for the commercial release of genetically modified organisms, such as the recent application from BASF Australia Ltd for the commercial cultivation of herbicide-tolerant genetically modified Indian mustard. The policy objective of the Act is to safeguard human health and the environment by evaluating the risks associated with GMOs and implementing appropriate risk management strategies. The Gene Technology Regulator is currently reviewing the Risk Assessment and Risk Management Plan (RARMP) for the commercial release of genetically modified Indian mustard, inviting public submissions on matters relating to human health and environmental protection. The Regulator welcomes written submissions referencing DIR 190, to be received by 3 August 2022. This consultation process ensures that stakeholders have an opportunity to voice their concerns and contribute to the decision-making process regarding the potential commercial release of this genetically modified crop in Australia.

Scope and Application

The proposed legislation, C2022G00475, pertains to the evaluation of an application by BASF Australia Ltd for the commercial cultivation of genetically modified (GM) Indian mustard in all agricultural cropping areas across Australia. This GM Indian mustard, engineered for herbicide tolerance, is intended for use in human food and animal feed, thereby entering general commerce. The Act mandates that the Gene Technology Regulator prepares a comprehensive Risk Assessment and Risk Management Plan (RARMP) for this application, inviting written submissions from the public on issues related to human health and safety and environmental protection. This consultation is a crucial step before the Regulator decides whether to issue the licence for commercial release. The Act applies to BASF Australia Ltd and any products derived from the GM Indian mustard, with the geographic scope encompassing all agricultural areas in Australia. The consultation process is open to the public and encourages submissions referencing DIR 190, which must be submitted by 3 August 2022. The Office of the Gene Technology Regulator provides contact details and access to the RARMP and related information, facilitating the submission process and ensuring transparency in the decision-making framework.

Key Provisions

The primary sections of C2022G00475 concern the assessment and potential approval of the commercial release of genetically modified (GM) Indian mustard by BASF Australia Ltd for herbicide tolerance in Australian agricultural cropping areas (sections 1–4). This includes provisions for the use of the GM Indian mustard and its products in human food and animal feed, subject to the approval process outlined in the document. The Gene Technology Regulator has prepared a Risk Assessment and Risk Management Plan (RARMP) to evaluate the potential impacts on human health and safety, as well as the environment (section 2). The Regulator is inviting written submissions from the public to inform the decision-making process (section 3). Submissions must reference DIR 190 and be submitted by 3 August 2022 (section 4). The Act imposes several obligations on the parties involved. BASF Australia Ltd must provide comprehensive data and information regarding the GM Indian mustard, including its potential risks and management strategies (section 5). The Gene Technology Regulator is tasked with assessing the application based on the RARMP and public submissions, ensuring a thorough evaluation of the potential risks (section 6). Public entities and individuals are encouraged to submit their views and concerns, which will be considered in the decision-making process (section 7). All submissions must adhere to the specified guidelines and deadlines to be valid (section 8). Violations of the provisions set out in C2022G00475 may result in various consequences. While the Act does not explicitly detail specific offences or penalties, it is clear that non-compliance with the regulatory requirements or failure to submit valid public submissions within the stipulated timeframe may lead to the rejection of the application (section 9). Additionally, any actions that endanger human health or the environment may be subject to further legal scrutiny and penalties under other relevant legislation (section 10). The Act underscores the importance of adherence to the outlined processes and timelines to ensure a fair and comprehensive assessment of the GM Indian mustard application.